» Articles » PMID: 18587056

Overexpression of Apoptotic Cell Removal Receptor MERTK in Alveolar Macrophages of Cigarette Smokers

Overview
Date 2008 Jul 1
PMID 18587056
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Mononuclear phagocytes play an important role in the removal of apoptotic cells by expressing cell surface receptors that recognize and remove apoptotic cells. Based on the knowledge that cigarette smoking is associated with increased lung cell turnover, we hypothesized that alveolar macrophages (AMs) of normal cigarette smokers may exhibit enhanced expression of apoptotic cell removal receptor genes. AMs obtained by bronchoalveolar lavage of normal nonsmokers (n = 11) and phenotypic normal smokers (n = 13; 36 +/- 6 pack-years) were screened for mRNA expression of all known apoptotic cell removal receptors using Affymetrix HG-U133 Plus 2.0 microarray chips with TaqMan RT-PCR confirmation. Of the 14 known apoptotic receptors expressed, only MER tyrosine kinase (MERTK), a transmembrane tyrosine kinase receptor, was significantly up-regulated in smokers. MERTK expression was then assessed in AMs of smokers versus nonsmokers by TaqMan RT-PCR, immunocytochemistry, Western analysis, and flow analysis. Smoker AMs had up-regulation of MERTK mRNA levels (smoker vs. nonsmoker: 3.6-fold by microarray, P < 0.003; 9.5-fold by TaqMan RT-PCR, P < 0.02). Immunocytochemistry demonstrated a qualitative increase in MERTK protein expression on AMs of smokers. Increased protein expression of MERTK on AMs of smokers was confirmed by Western and flow analyses (P < 0.007 and P < 0.0002, respectively). MERTK, a cell surface receptor that recognizes apoptotic cells, is expressed on human AMs, and its expression is up-regulated in AMs of cigarette smokers. This up-regulation of MERTK may reflect an increased demand for removal of apoptotic cells in smokers, an observation with implications for the development of chronic obstructive pulmonary disease, a disorder associated with dysregulated apoptosis of lung parenchymal cells.

Citing Articles

Efferocytosis and inflammation: a bibliometric and systematic analysis.

Cao X, Li F, Xie X, Ling G, Tang X, He W Front Med (Lausanne). 2025; 12:1498503.

PMID: 39995691 PMC: 11847848. DOI: 10.3389/fmed.2025.1498503.


Dissecting metabolic landscape of alveolar macrophage.

Malla S, Sajeevan K, Acharya B, Chowdhury R, Saha R Sci Rep. 2024; 14(1):30383.

PMID: 39638830 PMC: 11621776. DOI: 10.1038/s41598-024-81253-w.


Tissue-Resident Alveolar Macrophages Reduce Ozone-induced Inflammation via MerTK-mediated Efferocytosis.

Guttenberg M, Vose A, Birukova A, Lewars K, Cumming R, Albright M Am J Respir Cell Mol Biol. 2024; 70(6):493-506.

PMID: 38386777 PMC: 11160417. DOI: 10.1165/rcmb.2023-0390OC.


Tissue-resident alveolar macrophages reduce O-induced inflammation via MerTK mediated efferocytosis.

Guttenberg M, Vose A, Birukova A, Lewars K, Cumming R, Albright M bioRxiv. 2023; .

PMID: 37986982 PMC: 10659406. DOI: 10.1101/2023.11.06.565865.


Cluster Headache Genomewide Association Study and Meta-Analysis Identifies Eight Loci and Implicates Smoking as Causal Risk Factor.

Winsvold B, Harder A, Ran C, Chalmer M, Dalmasso M, Ferkingstad E Ann Neurol. 2023; 94(4):713-726.

PMID: 37486023 PMC: 10952302. DOI: 10.1002/ana.26743.


References
1.
Leopold P, Ferris B, Grinberg I, Worgall S, Hackett N, Crystal R . Fluorescent virions: dynamic tracking of the pathway of adenoviral gene transfer vectors in living cells. Hum Gene Ther. 1998; 9(3):367-78. DOI: 10.1089/hum.1998.9.3-367. View

2.
Umino T, Skold C, Pirruccello S, Spurzem J, Rennard S . Two-colour flow-cytometric analysis of pulmonary alveolar macrophages from smokers. Eur Respir J. 1999; 13(4):894-9. DOI: 10.1034/j.1399-3003.1999.13d33.x. View

3.
Keating A, Salzberg D, Sather S, Liang X, Nickoloff S, Anwar A . Lymphoblastic leukemia/lymphoma in mice overexpressing the Mer (MerTK) receptor tyrosine kinase. Oncogene. 2006; 25(45):6092-100. DOI: 10.1038/sj.onc.1209633. View

4.
Barnes P . Alveolar macrophages in chronic obstructive pulmonary disease (COPD). Cell Mol Biol (Noisy-le-grand). 2004; 50 Online Pub:OL627-37. View

5.
Guttridge K, Luft J, Dawson T, Kozlowska E, Mahajan N, Varnum B . Mer receptor tyrosine kinase signaling: prevention of apoptosis and alteration of cytoskeletal architecture without stimulation or proliferation. J Biol Chem. 2002; 277(27):24057-66. DOI: 10.1074/jbc.M112086200. View